Meeting
2023 ASCO Genitourinary Cancers Symposium
The natural progression of patients with an IsoPSA value and its predictive ability of clinically significant prostate cancer on biopsy.
Authors
Nour Abdallah
Cleveland Clinc, Cleveland, OH
Nour Abdallah , Tarik Benidir , Zaeem M Lone , Ao Zhang , Andrew Wood , Caleb Curry , Samuel Haywood , Jihad Kaouk , Robert Abouassaly , Eric A. Klein , Christopher J. Weight
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 325)
DOI
10.1200/JCO.2023.41.6_suppl.325
Abstract #
325
Poster Bd #
L3
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Cost-effectiveness analysis of magnetic resonance imaging-ultrasound fusion biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer.
First Author: Matthew Ingham
Poster
2016 Genitourinary Cancers Symposium
MRI-transrectal ultrasound cognitive fusion-targeted transperineal template-guided saturation prostate biopsies in a consecutive cohort of men.
First Author: Haim Matzkin
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of multiparametric magnetic resonance imaging findings with oncologic outcomes in non-palpable localized prostate cancer.
First Author: Abhishek Kumar
Poster
2024 ASCO Genitourinary Cancers Symposium
Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system.
First Author: Richard Bennett IV